Acta Scientific Microbiology

Research Article Volume 8 Issue 4

Adequate Method of Hepatitis C Virus (HCV) RNA Quantitation and Geographical Distribution of Subjects in Eastern Uttar Pradesh: Findings from a Tertiary Care Hospital

Vivek Gaur*

Department of Microbiology, Baba Raghav Das Medical College Gorakhpur, Uttar Pradesh, India

*Corresponding Author: Vivek Gaur, Department of Microbiology, Baba Raghav Das Medical College Gorakhpur, Uttar Pradesh, India.

Received: February 17, 2025; Published: March 20, 2024

Reprints View PDF Related Articles

Abstract

Background: Hepatitis C virus (HCV) have several important features, including worldwide distribution, hepatotropism, modes of transmission, ability to life threatening critical illness and is a growing public health issue worldwide. It’s prevalence and mode of transmission varies greatly in different parts of the world. It is estimated that approximately one-fifth of the world population infected with HCV.

Aim of the Study: This study was planned to know the prevalence, demographic and geographical distribution of HCV in eastern Uttar Pradesh, India.

Material and Methods: An observational study was conducted in the department of Microbiology for 2 years from January 2023 to December 2024. Irrespective of age and sex, a non-duplicate blood samples were taken to detect HCV infection. All samples were tested for rapid HCV antibody test followed by viral load testing by using RT-PCR technique.

Results were interpreted according to standard protocol.

Results: Out of 1831 patient’s samples, 1266 (69.14%) patients were from outpatient department (OPD) and 565 (30.86%) were from inpatient department (IPD). 1053 (57.50%) were male patients and 778 (42.49%) were female patients. In study, most of the patients visited in MTC unit from Gorakhpur division (69.85%) of Uttar Pradesh followed by Basti (13%) division. Among positive cases, only 5.83% of cases has viral load less than 300 IU/ml.

Conclusion: Hepatitis virus infection was highest in the age group 19-40 and lowest in the age group above <18 years. Hepatitis C was more in males as compared to females and more in OPD as compared to IPD.

Keywords: Hepatitis C Virus; Hepatocellular Carcinoma; Eastern Mediterranean Region; National Viral Hepatitis Control Program; HCV Prevalence; HCV in Eastern Uttar Pradesh

References

  1. Axley P., et al. “Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review”. Journal of Clinical and Translational Hepatology6.1 (2018): 79-84.
  2. Mehta P., et al. “Viral Hepatitis”. Treasure Island (FL): Stat Pearls Publishing; (2024). 
  3. Zaltron S., et al. “Chronic HCV infection: epidemiological and clinical relevance”. BMC Infectious Disease12 (2012).
  4. Hepatitis C fact sheet (2024).
  5. Jothi BJ., et al. “Insights into the Epidemiology of Hepatitis C Virus Infection in Delhi: Findings from a Tertiary Care Hospital”. International Journal of Medicine and Public Health 3 (2023): 133-136.
  6. Olaru ID., et al. “Global prevalence of hepatitis B or hepatitis C infection among patients with tuberculosis disease: systematic review and meta-analysis”. E Clinical Medicine58 (2023): 101938.
  7. Puri P., et al. “Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India”. Journal of Clinical and Experimental Hepatology 2 (2012): 117-140.
  8. Dhiman RK., et al. “Tackling the Hepatitis C Disease Burden in Punjab, India”. Journal of Clinical and Experimental Hepatology 3 (2016): 224-232.
  9. Huang P., et al. “The risk of hepatitis C virus recurrence in hepatitis C virus-infected patients treated with direct-acting antivirals after achieving a sustained virological response: A comprehensive analysis”. Liver International10 (2021): 2341-2357.
  10. Web Annex C. Estimates of the coverage of diagnosis and treatment for hepatitis B and C virus infection, by WHO region and income group, 2015. Centre for Disease Analysis. In: Global hepatitis report 2017 (2017).
  11. Jeong D., et al. “Treatment of HCV with direct-acting antivirals on reducing mortality related to extrahepatic manifestations: a large population-based study in British Columbia, Canada”. The Lancet Regional Health – Americas 29 (2023):
  12. Q-line Biotech. Rapid test. HCV Antibody (3rd Generation).
  13. Molbio Diagnostics Limited. Truenat HCV. Chip-based Real Time PCR Test for Hepatitis C Virus.
  14. Sivaranjini K., et al. “Spectrum of hepatitis B and hepatitis C-related cancers in India”.E cancer 18 (2024):
  15. Shaikh KD., et al. “Hepatitis in India: challenges, efforts, and recommendations”. International Journal of Surgery: Global Health2 (2021): e118.
  16. Oberoi ML., et al. “Prevalence of Acute Viral Hepatitis in Symptomatic Patients in a Tertiary Care Hospital of North India”. Journal of Advances in Microbiology 11 (2022): 67-71.
  17. Parveen M., et al. “Prevalence of Hepatitis B and Hepatitis C in Tertiary Care Center of Northern India”. Advanced Research in Gastroenterology and Hepatology 4 (2020): 555918.
  18. Irshad M., et al. “Viral hepatitis in India: Current status”. Gastroenterology Hepatology and Endoscopy 1 (2018).
  19. Wait S., et al. “Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments”. Lancet Gastroenterology and Hepatology3 (2016): 248-255.
  20. Bhaumik P. “Epidemiology of Viral Hepatitis and Liver Diseases in India”. Euroasian Journal of Hepato-gastroenterology 1 (2015): 34-36.
  21. Bhate P., et al. “Cross sectional study of prevalence and risk factors of hepatitis b and hepatitis c infection in a rural village of India”. Arquivos de Gastroenterologia 4 (2015): 321-324.

Citation

Citation: Vivek Gaur. “Adequate Method of Hepatitis C Virus (HCV) RNA Quantitation and Geographical Distribution of Subjects in Eastern Uttar Pradesh: Findings from a Tertiary Care Hospital".Acta Scientific Microbiology 8.4 (2025): 27-31.

Copyright

Copyright: © 2025 Vivek Gaur. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days

Indexed In






News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.

Contact US





Creative Commons License Open Access by Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com

ff

Acta-Publications

ff

© 2021 Acta Scientific, All rights reserved.